Literature DB >> 8962079

No .NO from NO synthase.

H H Schmidt1, H Hofmann, U Schindler, Z S Shutenko, D D Cunningham, M Feelisch.   

Abstract

The nitric-oxide synthase (NOS; EC 1.14.13.39) reaction is formulated as a partially tetrahydrobiopterin (H4Bip)-dependent 5-electron oxidation of a terminal guanidino nitrogen of L-arginine (Arg) associated with stoichiometric consumption of dioxygen (O2) and 1.5 mol of NADPH to form L-citrulline (Cit) and nitric oxide (.NO). Analysis of NOS activity has relied largely on indirect methods such as quantification of nitrite/nitrate or the coproduct Cit; we therefore sought to directly quantify .NO formation from purified NOS. However, by two independent methods, NOS did not yield detectable .NO unless superoxide dismutase (SOD; EC 1.15.1.1) was present. In the presence of H4Bip, internal .NO standards were only partially recovered and the dismutation of superoxide (O2-.), which otherwise scavenges. .NO to yield ONOO-, was a plausible mechanism of action of SOD. Under these conditions, a reaction between NADPH and ONOO- resulted in considerable overestimation of enzymatic NADPH consumption. SOD lowered the NADPH:Cit stoichiometry to 0.8-1.1, suggesting either that additional reducing equivalents besides NADPH are required to explain Arg oxidation to .NO or that .NO was not primarily formed. The latter was supported by an additional set of experiments in the absence of H4Bip. Here, recovery of internal .NO standards was unaffected. Thus, a second activity of SOD, the conversion of nitroxyl (NO-) to .NO, was a more likely mechanism of action of SOD. Detection of NOS-derived nitrous oxide (N2O) and hydroxylamine (NH2OH), which cannot arise from .NO decomposition, was consistent with formation of an .NO precursor molecule such as NO-. When, in the presence of SOD, glutathione was added, S-nitrosoglutathione was detected. Our results indicate that .NO is not the primary reaction product of NOS-catalyzed Arg turnover and an alternative reaction mechanism and stoichiometry have to be taken into account.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962079      PMCID: PMC26160          DOI: 10.1073/pnas.93.25.14492

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Ca2+-dependent formation of an L-arginine-derived activator of soluble guanylyl cyclase in bovine lung.

Authors:  B Mayer; E Böhme
Journal:  FEBS Lett       Date:  1989-10-09       Impact factor: 4.124

4.  Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells.

Authors:  H H Schmidt; B Zernikow; S Baeblich; E Böhme
Journal:  J Pharmacol Exp Ther       Date:  1990-08       Impact factor: 4.030

5.  Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages.

Authors:  N S Kwon; C F Nathan; D J Stuehr
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

6.  Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor.

Authors:  M A Tayeh; M A Marletta
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

7.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase.

Authors:  H H Schmidt; J S Pollock; M Nakane; L D Gorsky; U Förstermann; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

9.  Arginine is a physiological precursor of endothelium-derived nitric oxide.

Authors:  H H Schmidt; H Nau; W Wittfoht; J Gerlach; K E Prescher; M M Klein; F Niroomand; E Böhme
Journal:  Eur J Pharmacol       Date:  1988-09-13       Impact factor: 4.432

10.  An assay method for nitric oxide synthase in crude samples by determining product NADP.

Authors:  W Wang; N Inoue; T Nakayama; M Ishii; T Kato
Journal:  Anal Biochem       Date:  1995-05-20       Impact factor: 3.365

View more
  63 in total

1.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.

Authors:  C G Li; J Karagiannis; M J Rand
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Nitroxyl gets to the heart of the matter.

Authors:  Martin Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

Review 3.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

4.  A novel role for HNO in local and spreading vasodilatation in rat mesenteric resistance arteries.

Authors:  Kathryn H Yuill; Polina Yarova; Barbara K Kemp-Harper; Christopher J Garland; Kim A Dora
Journal:  Antioxid Redox Signal       Date:  2010-10-07       Impact factor: 8.401

5.  Oxidative neuropathology and putative chemical entities for Alzheimer's disease: neuroprotective effects of salen-manganese catalytic anti-oxidants.

Authors:  H T Rupniak; K A Joy; C Atkin; G Brown; J C Barnes; S R Doctrow; B Malfroy; T Wong; I K Anderson; C R Molloy; G I Mills; P Soden
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 6.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 7.  Causes and consequences of methamphetamine and MDMA toxicity.

Authors:  Maria S Quinton; Bryan K Yamamoto
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

Review 8.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

9.  The reduction potential of nitric oxide (NO) and its importance to NO biochemistry.

Authors:  Michael D Bartberger; Wei Liu; Eleonora Ford; Katrina M Miranda; Christopher Switzer; Jon M Fukuto; Patrick J Farmer; David A Wink; Kendall N Houk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

10.  A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system.

Authors:  Katrina M Miranda; Nazareno Paolocci; Tatsuo Katori; Douglas D Thomas; Eleonora Ford; Michael D Bartberger; Michael G Espey; David A Kass; Martin Feelisch; Jon M Fukuto; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.